# Octapharma Plasma, Inc. – FDA Inspection, Jan 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/9366c105-dc61-45df-8892-13ad4d3bdcf4
Source feed: FDA_Inspections

> FDA inspection 1004544 of Octapharma Plasma, Inc., January 26, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1004544
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2017-01-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1291170 - 2026-09-16
- FDA Inspection 1315790 - 2026-04-17
- FDA Inspection 1313722 - 2026-04-17
- FDA Inspection 1298618 - 2026-01-09
- FDA Inspection 1255733 - 2024-11-21

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/julie-d-bringger/4f6b1f96-e559-45bd-bb73-5354ce64552d)
- Issuing Officer

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/0ac5072d-2e4e-4a6e-844e-6a7c763152b8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d